Eye drop trial aims to slow vision loss from cataracts
NCT ID NCT07395986
Summary
This study is testing whether a new eye drop called ZOC2017217 can help control age-related cataracts. About 40 adults with cataracts will use the eye drop or a placebo twice daily for 24 weeks to see if it improves vision clarity, reduces cloudiness in the eye's lens, and is safe. The goal is to see if this treatment can slow cataract progression and delay the need for surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE RELATED CATARACTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bergstrom Eye Research
Fargo, North Dakota, 58103, United States
-
Cincinnati Eye Institute - Blue Ash
Blue Ash, Ohio, 45242, United States
-
Clayton Eye Clinical Research, LLC
Morrow, Georgia, 30260, United States
-
East West Eye Institute - Torrance
Torrance, California, 90505, United States
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Global Research Management
Glendale, California, 91204, United States
-
ICON Eye Care
Grand Junction, Colorado, 81501, United States
-
Levenson Eye Associates
Jacksonville, Florida, 32204, United States
-
North Bay Eye Associates, Inc.
Petaluma, California, 94954, United States
-
Oculus Research - Cary
Cary, North Carolina, 27518, United States
-
R and R Eye Research, LLC
San Antonio, Texas, 78229, United States
-
Rand Eye Institute
Deerfield Beach, Florida, 33064, United States
-
United Medical Research Institute
Inglewood, California, 90301, United States
Conditions
Explore the condition pages connected to this study.